Mississauga, ON -- (SBWIRE) -- 07/14/2014 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “ActiveCare Adds 1200 Diabetes Patients to Monitoring Platform in July.”
Companies mentioned in this article include ActiveCare, Inc. (OTCQB:ACAR).
Probably the most underemphasized epidemic in the U.S., if not the whole world, is diabetes, a chronic disease with a bevy of co-morbidities that has swept across the globe at an alarming rate. While swift killer like cancer usually takes the headlines and subject of focus for the biotechnology industry, the numbers behind diabetes should command more attention. In June, the Centers for Disease Control and Prevention released their latest figures on diabetes prevalence in 2012, showing that 29 million people in the U.S. had diabetes, up by about 12 percent from 26 million only two years earlier. According to the CDC, another 86 million people are what doctors call “pre-diabetic,” essentially meaning that they have high blood sugar levels that can turn into diabetes if not controlled. Add it up and that’s more than a third of the U.S. population and if the trend continues, half of the population will be diabetic or pre-diabetic in the next six years. The burden on the nation’s health care system is tremendous and growing quickly, with diabetes and related complications costing $245 billion in 2012, versus $174 billion in 2010.
Digital technologies are fully developed and being deployed to help overcome physician shortages, promote better compliance in diabetes management and control costs. ActiveCare, Inc. (OTCQB:ACAR) is one of the companies to first bring their platform to the commercial marketplace and it seems that self-insured employers are embracing the offering. The company uses blood glucose meters with embedded cellular technology, which automatically uploads data from the meter to a HIPAA secure web portal where it can be monitored by specified members of the patient’s support team. Alerts can be set to notify the property parties if readings are outside predefined parameters. CareSpecialists are on call 24/7 to intervene in real-time and provide members with the support needed to control their disease.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.